{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:13:39Z","timestamp":1793506419685,"version":"4.5.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nanoparticles have now long demonstrated capabilities that make them attractive to use in biology and medicine. Some of them, such as lipid nanoparticles\u00a0(SARS-CoV-2 vaccines) or metallic nanoparticles (contrast agents) are already approved for their use in the clinic. However, considering the constantly growing body of different formulations and the huge research around nanomaterials the number of candidates reaching clinical trials or being commercialized is minimal. The reasons behind being related to the \u201csynthetic\u201d and \u201cforeign\u201d character of their surface. Typically, nanomaterials aiming to develop a function or deliver a cargo locally, fail by showing strong off-target accumulation and generation of adverse responses, which is connected to their strong recognition by immune phagocytes primarily. Therefore, rendering in negligible numbers of nanoparticles developing their intended function. While a wide range of coatings has been applied to avoid certain interactions with the surrounding milieu, the issues remained. Taking advantage of the natural cell membranes, in an approach that resembles a cell transfer, the use of cell-derived surfaces has risen as an alternative to artificial coatings or encapsulation methods. Biomimetic technologies are based on the use of isolated natural components to provide autologous properties to the nanoparticle or cargo being encapsulated, thus, improving their therapeutic behavior. The main goal is to replicate the (bio)-physical properties and functionalities of the source cell and tissue, not only providing a stealthy character to the core but also taking advantage of homotypic properties, that could prove relevant for targeted strategies. Such biomimetic formulations have the potential to overcome the main issues of approaches to provide specific features and identities synthetically. In this review, we provide insight into the challenges of nano-biointerfaces for drug delivery; and the main applications of biomimetic materials derived from specific cell types, focusing on the unique strengths of the fabrication of novel nanotherapeutics in cancer therapy.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-022-01748-4","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T22:02:29Z","timestamp":1671660149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Biomimetic cell-derived nanocarriers in cancer research"],"prefix":"10.1186","volume":"20","author":[{"given":"Enrica","family":"Soprano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Pelaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"del Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"1748_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101\u201324.","journal-title":"Nat Rev Drug Discov"},{"key":"1748_CR2","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","volume":"53","author":"T Sun","year":"2014","unstructured":"Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed. 2014;53:12320\u201364.","journal-title":"Angew Chem Int Ed"},{"key":"1748_CR3","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","volume":"11","author":"B Pelaz","year":"2017","unstructured":"Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11:2313\u201381.","journal-title":"ACS Nano"},{"key":"1748_CR4","doi-asserted-by":"publisher","first-page":"1704307","DOI":"10.1002\/adma.201704307","volume":"30","author":"J Bourquin","year":"2018","unstructured":"Bourquin J, Milosevic A, Hauser D, Lehner R, Blank F, Petri-Fink A, Rothen-Rutishauser B. Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv Mater. 2018;30:1704307.","journal-title":"Adv Mater"},{"key":"1748_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","volume":"66","author":"N Bertrand","year":"2014","unstructured":"Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2\u201325.","journal-title":"Adv Drug Deliv Rev"},{"key":"1748_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1\u201316.","journal-title":"Annu Rev Biomed Eng"},{"issue":"6","key":"1748_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1469-7580.2002.00066.x","volume":"200","author":"DO Bates","year":"2002","unstructured":"Bates DO. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat. 2002;200(6):581\u201397.","journal-title":"J Anat"},{"key":"1748_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","volume":"161","author":"F Kiessling","year":"2012","unstructured":"Kiessling F, Hennink WE, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161:175\u201387.","journal-title":"J Control Release"},{"key":"1748_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/sj.bjc.6604483","volume":"99","author":"T Lammers","year":"2008","unstructured":"Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer. 2008;99:392\u20137.","journal-title":"Br J Cancer"},{"key":"1748_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.drudis.2010.08.006","volume":"15","author":"R Misra","year":"2010","unstructured":"Misra R, Acharya S, Sahoo SK. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today. 2010;15:842\u201350.","journal-title":"Drug Discov Today"},{"key":"1748_CR11","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1016\/j.biomaterials.2009.07.008","volume":"30","author":"S Acharya","year":"2009","unstructured":"Acharya S, Dilnawaz F, Sahoo SK. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials. 2009;30:5737\u201350.","journal-title":"Biomaterials"},{"key":"1748_CR12","first-page":"8010","volume":"32","author":"J Guo","year":"2011","unstructured":"Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma. drug delivery Biomaterials. 2011;32:8010\u201320.","journal-title":"drug delivery Biomaterials"},{"key":"1748_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2009.08.024","volume":"141","author":"M Hong","year":"2010","unstructured":"Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. J Control Release. 2010;141:22\u20139.","journal-title":"J Control Release"},{"key":"1748_CR14","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2217\/nnm.12.160","volume":"12","author":"AM Master","year":"2012","unstructured":"Master AM, Sen Gupta A. EGF receptor-targeted nanocarriers for enhanced cancer treatment. Nanomed (Lond). 2012;12:1895\u2013906.","journal-title":"Nanomed (Lond)"},{"key":"1748_CR15","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1016\/j.biomaterials.2011.04.006","volume":"32","author":"NV Nukolova","year":"2011","unstructured":"Nukolova NV, Oberoi HS, Cohen SM, Kabanov AV, Bronich TK. Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials. 2011;32:5417\u201326.","journal-title":"Biomaterials"},{"key":"1748_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biomaterials.2016.04.004","volume":"94","author":"H Xiong","year":"2016","unstructured":"Xiong H, Du S, Ni J, Zhou J, Yao J. Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin. Biomaterials. 2016;94:70\u201383.","journal-title":"Biomaterials"},{"key":"1748_CR17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/asia.200700301","volume":"3","author":"C Xu","year":"2008","unstructured":"Xu C, Xie J, Kohler N, Walsh EG, Chin YE, Sun S. Monodisperse magnetite nanoparticles coupled with nuclear localization signal peptide for cell-nucleus targeting. Asian J Chem. 2008;3:548\u201352.","journal-title":"Asian J Chem"},{"key":"1748_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4161\/cbt.13.1.18871","volume":"13","author":"A Koshkaryev","year":"2012","unstructured":"Koshkaryev A, Piroyan A, Torchilin VP. Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes. Cancer Bio Ther. 2012;13:50\u201360.","journal-title":"Cancer Bio Ther"},{"key":"1748_CR19","doi-asserted-by":"publisher","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","volume":"15","author":"V Chugh","year":"2021","unstructured":"Chugh V, Vijaya Krishna K, Pandit A. Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation. ACS Nano. 2021;15:17080\u2013123.","journal-title":"ACS Nano"},{"key":"1748_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022;185:250\u201365. e216.","journal-title":"Cell"},{"key":"1748_CR21","doi-asserted-by":"publisher","first-page":"1802896","DOI":"10.1002\/adma.201802896","volume":"31","author":"B Yang","year":"2019","unstructured":"Yang B, Chen Y, Shi J. Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Adv Mater. 2019;31:1802896.","journal-title":"Adv Mater"},{"key":"1748_CR22","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1021\/acsnano.7b01197","volume":"11","author":"E Polo","year":"2017","unstructured":"Polo E, Collado M, Pelaz B, Del Pino P. Advances toward more efficient targeted delivery of nanoparticles in vivo: understanding interactions between nanoparticles and cells. ACS Nano. 2017;11:2397\u2013402.","journal-title":"ACS Nano"},{"key":"1748_CR23","doi-asserted-by":"publisher","first-page":"10471","DOI":"10.1021\/acsnano.6b06411","volume":"10","author":"F Bertoli","year":"2016","unstructured":"Bertoli F, Garry D, Monopoli MP, Salvati A, Dawson KA. The intracellular destiny of the protein corona: a study on its cellular internalization and evolution. ACS Nano. 2016;10:10471\u20139.","journal-title":"ACS Nano"},{"key":"1748_CR24","doi-asserted-by":"publisher","first-page":"1909999","DOI":"10.1002\/adfm.201909999","volume":"30","author":"L Cai","year":"2020","unstructured":"Cai L, Yang C, Jia W, Liu Y, Xie R, Lei T, Yang Z, He X, Tong R, Gao H. Endo\/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer\u2019s disease. Adv Funct Mater. 2020;30:1909999.","journal-title":"Adv Funct Mater"},{"key":"1748_CR25","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, St\u00f6ter M. Image-based analysis of lipid nanoparticle\u2013mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat biotechnol. 2013;31:638\u201346.","journal-title":"Nat biotechnol"},{"key":"1748_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nbt.3816","volume":"35","author":"K Kim","year":"2017","unstructured":"Kim K, Ryu SM, Kim ST, Baek G, Kim D, Lim K, Chung E, Kim S, Kim JS. Highly efficient RNA-guided base editing in mouse embryos. Nat biotechnol. 2017;35:435\u20137.","journal-title":"Nat biotechnol"},{"key":"1748_CR27","first-page":"1692","volume":"171","author":"D Clift","year":"2017","unstructured":"Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M. A method for the acute and rapid degradation of. Endogenous Proteins Cell. 2017;171:1692-706.e1618.","journal-title":"Endogenous Proteins Cell"},{"key":"1748_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nmeth.3475","volume":"12","author":"I K\u00f6nig","year":"2015","unstructured":"K\u00f6nig I, Zarrine-Afsar A, Aznauryan M, Soranno A, Wunderlich B, Dingfelder F, St\u00fcber JC, Pl\u00fcckthun A, Nettels D, Schuler B. Single-molecule spectroscopy of protein conformational dynamics in live eukaryotic cells. Nat Methods. 2015;12:773\u20139.","journal-title":"Nat Methods"},{"key":"1748_CR29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1021\/mp100253e","volume":"7","author":"W Gao","year":"2010","unstructured":"Gao W, Chan JM, Farokhzad OC. PH-responsive nanoparticles for drug delivery. Mol Pharm. 2010;7:1913\u201320.","journal-title":"Mol Pharm."},{"key":"1748_CR30","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.1021\/acsnano.5b04306","volume":"9","author":"Z Li","year":"2015","unstructured":"Li Z, Clemens DL, Lee BY, Dillon BJ, Horwitz MA, Zink JI. Mesoporous silica nanoparticles with pH-sensitive nanovalves for delivery of moxifloxacin provide Improved treatment of lethal pneumonic tularemia. ACS Nano. 2015;9:10778\u201389.","journal-title":"ACS Nano"},{"key":"1748_CR31","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1021\/mp5000482","volume":"11","author":"RB Remant","year":"2014","unstructured":"Remant RB, Chandrashekaran V, Cheng B, Chen H, Pe\u00f1a MMO, Zhang J, Montgomery J, Xu P. Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells. Mol Pharm. 2014;11:1897\u2013905.","journal-title":"Mol Pharm"},{"key":"1748_CR32","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1039\/C7SC00472A","volume":"8","author":"B Renoux","year":"2017","unstructured":"Renoux B, Raes F, Legigan T, P\u00e9raudeau E, Eddhif B, Poinot P, Tranoy-Opalinski I, Alsarraf J, Koniev O, Kolodych S, et al. Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers. Chem Sci. 2017;8:3427\u201333.","journal-title":"Chem Sci"},{"key":"1748_CR33","doi-asserted-by":"publisher","first-page":"12518","DOI":"10.1021\/acsami.8b02398","volume":"10","author":"E Guisasola","year":"2018","unstructured":"Guisasola E, As\u00edn L, Beola L, De La Fuente JM, Baeza A, Vallet-Reg\u00ed M. Beyond traditional hyperthermia: in vivo cancer treatment with magnetic-responsive mesoporous silica nanocarriers. ACS Appl Mater Interfaces. 2018;10:12518\u201325.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1748_CR34","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.1039\/C5NR03777H","volume":"7","author":"P Saint-Cricq","year":"2015","unstructured":"Saint-Cricq P, Deshayes S, Zink JI, Kasko AM. Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica nanoparticles. Nanoscale. 2015;7:13168\u201372.","journal-title":"Nanoscale"},{"key":"1748_CR35","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1021\/acsnano.5b04378","volume":"9","author":"JL Paris","year":"2015","unstructured":"Paris JL, Cabanas MV, Manzano M, Vallet-Reg\u00ed M. Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers. ACS Nano. 2015;9:11023\u201333.","journal-title":"ACS Nano"},{"key":"1748_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1073\/pnas.1714421115","volume":"115","author":"M Qiu","year":"2018","unstructured":"Qiu M, Wang D, Liang W, Liu L, Zhang Y, Chen X, Sang DK, Xing C, Li Z, Dong B, et al. Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy. Proc Natl Acad Sci U S A. 2018;115:501\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1748_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jconrel.2008.06.022","volume":"132","author":"C Lin","year":"2008","unstructured":"Lin C, Engbersen JFJ. Effect of chemical functionalities in poly(amido amine)s for non-viral gene transfection. J Control Release. 2008;132:267\u201372.","journal-title":"J Control Release"},{"key":"1748_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.2998","volume":"11","author":"A Erazo-Oliveras","year":"2014","unstructured":"Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. Protein delivery into live cells by incubation with an endosomolytic agent. Nat Methods. 2014;11:861\u20137.","journal-title":"Nat Methods"},{"key":"1748_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.addr.2003.10.041","volume":"56","author":"W Li","year":"2004","unstructured":"Li W, Nicol F, Szoka FC. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev. 2004;56:967\u201385.","journal-title":"Adv Drug Deliv Rev"},{"key":"1748_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nchem.2779","volume":"9","author":"M Akishiba","year":"2017","unstructured":"Akishiba M, Takeuchi T, Kawaguchi Y, Sakamoto K, Yu HH, Nakase I, Takatani-Nakase T, Madani F, Gr\u00e4slund A, Futaki S. Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nat Chem. 2017;9:751\u201361.","journal-title":"Nat Chem"},{"key":"1748_CR41","doi-asserted-by":"publisher","first-page":"e3300","DOI":"10.1002\/psc.3300","volume":"27","author":"S Reissmann","year":"2021","unstructured":"Reissmann S, Filatova MP. New generation of cell-penetrating peptides: functionality and potential clinical application. J Pept Sci. 2021;27:e3300.","journal-title":"J Pept Sci"},{"key":"1748_CR42","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1021\/acs.accounts.7b00221","volume":"50","author":"S Futaki","year":"2017","unstructured":"Futaki S, Nakase I. Cell-surface interactions on arginine-rich cell-penetrating peptides allow for multiplex modes of internalization. Acc Chem Res. 2017;50:2449\u201356.","journal-title":"Acc Chem Res"},{"key":"1748_CR43","doi-asserted-by":"publisher","first-page":"11868","DOI":"10.1002\/anie.201801361","volume":"57","author":"L Peraro","year":"2018","unstructured":"Peraro L, Kritzer JA. Emerging methods and design principles for cell-penetrant. Peptides Angew Chem Int Ed. 2018;57:11868\u201381.","journal-title":"Peptides Angew Chem Int Ed"},{"key":"1748_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41586-022-04413-w","volume":"603","author":"A Barba-Bon","year":"2022","unstructured":"Barba-Bon A, Salluce G, Lostal\u00e9-Seijo I, Assaf K, Hennig A, Montenegro J, Nau WM. Boron clusters as broadband membrane carriers. Nature. 2022;603:637\u201342.","journal-title":"Nature"},{"key":"1748_CR45","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00018-008-7570-z","volume":"65","author":"EE Heldwein","year":"2008","unstructured":"Heldwein EE, Krummenacher C. Entry of herpesviruses into mammalian cells. Cell Mol Life Sci. 2008;65:1653\u201368.","journal-title":"Cell Mol Life Sci"},{"key":"1748_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","volume":"6","author":"PG Spear","year":"2004","unstructured":"Spear PG. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol. 2004;6:401\u201310.","journal-title":"Cell Microbiol"},{"key":"1748_CR47","doi-asserted-by":"publisher","first-page":"10559","DOI":"10.1073\/pnas.0801674105","volume":"105","author":"UE Maurer","year":"2008","unstructured":"Maurer UE, Sodeik B, Gr\u00fcnewald K. Native 3D intermediates of membrane fusion in herpes simplex virus 1 entry. Proc Natl Acad Sci U S A. 2008;105:10559\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1748_CR48","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1073\/pnas.1811183115","volume":"115","author":"R Brian Dyer","year":"2018","unstructured":"Brian Dyer R, Eller MW. Dynamics of hemagglutinin-mediated membrane fusion. Proc Natl Acad Sci U S A. 2018;115:8655\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1748_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1535676019899502","volume":"25","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, Brown AM, Jenkins C, Campbell K. Viral vector systems for gene therapy: a comprehensive literature review of progress and biosafety challenges. Appl Biosaf. 2020;25:7\u201318.","journal-title":"Appl Biosaf"},{"key":"1748_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.addr.2004.09.005","volume":"57","author":"T Daemen","year":"2005","unstructured":"Daemen T, De Mare A, Bungener L, De Jonge J, Huckriede A, Wilschut J. Virosomes for antigen and DNA delivery. Adv Drug Deliv Rev. 2005;57:451\u201363.","journal-title":"Adv Drug Deliv Rev"},{"key":"1748_CR51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1021\/bc1002532","volume":"22","author":"Q Zhao","year":"2011","unstructured":"Zhao Q, Chen W, Chen Y, Zhang L, Zhang J, Zhang Z. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconj Chem. 2011;22:346\u201352.","journal-title":"Bioconj Chem"},{"key":"1748_CR52","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1021\/acsnano.8b01059","volume":"12","author":"NH Dashti","year":"2018","unstructured":"Dashti NH, Abidin RS, Sainsbury F. Programmable in vitro coencapsidation of guest proteins for intracellular delivery by virus-like particles. ACS Nano. 2018;12:4615\u201323.","journal-title":"ACS Nano"},{"key":"1748_CR53","doi-asserted-by":"publisher","first-page":"27410","DOI":"10.1074\/jbc.M313612200","volume":"279","author":"A Abbing","year":"2004","unstructured":"Abbing A, Blaschke UK, Grein S, Kretschmar M, Stark CMB, Thies MJW, Walter J, Weigand M, Woith DC, Hess J, Reiser COA. Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles. J Biol Chem. 2004;279:27410\u201321.","journal-title":"J Biol Chem"},{"key":"1748_CR54","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1021\/nn201397z","volume":"5","author":"CE Ashley","year":"2011","unstructured":"Ashley CE, Carnes EC, Phillips GK, Durfee PN, Buley MD, Lino CA, Padilla DP, Phillips B, Carter MB, Willman CL, et al. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. ACS Nano. 2011;5:5729\u201345.","journal-title":"ACS Nano"},{"key":"1748_CR55","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1021\/bm301278f","volume":"13","author":"AM Wen","year":"2012","unstructured":"Wen AM, Shukla S, Saxena P, Aljabali AAA, Yildiz I, Dey S, Mealy JE, Yang AC, Evans DJ, Lomonossoff GP, Steinmetz NF. Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules. 2012;13:3990\u20134001.","journal-title":"Biomacromolecules"},{"key":"1748_CR56","doi-asserted-by":"publisher","first-page":"16998","DOI":"10.1073\/pnas.1101874108","volume":"108","author":"SJ Kaczmarczyk","year":"2011","unstructured":"Kaczmarczyk SJ, Sitaraman K, Young HA, Hughes SH, Chatterjee DK. Protein delivery using engineered virus-like particles. Proc Natl Acad Sci U S A. 2011;108:16998\u20137003.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1748_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21803","volume":"6","author":"A Abraham","year":"2016","unstructured":"Abraham A, Natraj U, Karande AA, Gulati A, Murthy MRN, Murugesan S, Mukunda P, Savithri HS. Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles. Sci Rep. 2016;6:1\u201312.","journal-title":"Sci Rep"},{"key":"1748_CR58","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"D Bobo","year":"2016","unstructured":"Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based Medicines: a review of FDA-Approved materials and clinical trials to date. Pharm Res. 2016;33:2373\u201387.","journal-title":"Pharm Res"},{"key":"1748_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534:396\u2013401.","journal-title":"Nature"},{"key":"1748_CR60","doi-asserted-by":"publisher","first-page":"e1629259","DOI":"10.1080\/2162402X.2019.1629259","volume":"8","author":"C Grunwitz","year":"2019","unstructured":"Grunwitz C, Salomon N, Vascotto F, Selmi A, Bukur T, Diken M, Kreiter S, T\u00fcreci \u00d6, Sahin U. HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory. Oncoimmunology. 2019;8:e1629259.","journal-title":"Oncoimmunology"},{"key":"1748_CR61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","volume":"585","author":"U Sahin","year":"2020","unstructured":"Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020;585:107\u201312.","journal-title":"Nature"},{"key":"1748_CR62","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","volume":"586","author":"MJ Mulligan","year":"2020","unstructured":"Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA. Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589\u201393.","journal-title":"Nature"},{"key":"1748_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1021\/ar200105p","volume":"44","author":"T Al-jamal","year":"2011","unstructured":"Al-jamal T, Kostarelos K. Liposomes: from a clinically established Drug Delivery System to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res. 2011;44:48\u20138.","journal-title":"Acc Chem Res"},{"key":"1748_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1517\/17425247.2013.729576","volume":"10","author":"MS Muthu","year":"2013","unstructured":"Muthu MS, Feng SS. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. Expert Opin Drug Deliv. 2013;10:151\u20135.","journal-title":"Expert Opin Drug Deliv"},{"key":"1748_CR65","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","volume":"592","author":"S Boyoglu-Barnum","year":"2021","unstructured":"Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park Y-J, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature. 2021;592:623\u20138.","journal-title":"Nature"},{"key":"1748_CR66","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1021\/acsnano.9b00326","volume":"13","author":"FC Knight","year":"2019","unstructured":"Knight FC, Gilchuk P, Kumar A, Becker KW, Sevimli S, Jacobson ME, Suryadevara N, Wang-Bishop L, Boyd KL, Crowe JE Jr. Mucosal immunization with a pH-responsive nanoparticle vaccine induces protective CD8 + lung-resident memory T cells. ACS Nano. 2019;13:10939\u201360.","journal-title":"ACS Nano"},{"key":"1748_CR67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mattod.2021.08.002","volume":"50","author":"Q Mu","year":"2021","unstructured":"Mu Q, Lin G, Jeon M, Wang H, Chang F-C, Revia RA, Yu J, Zhang M. Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer. Mater Today. 2021;50:149\u201369.","journal-title":"Mater Today"},{"key":"1748_CR68","doi-asserted-by":"publisher","first-page":"e10143","DOI":"10.1002\/btm2.10143","volume":"4","author":"AC Anselmo","year":"2019","unstructured":"Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019;4:e10143.","journal-title":"Bioeng Transl Med"},{"key":"1748_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms13475","volume":"7","author":"MC Lo Giudice","year":"2016","unstructured":"Lo Giudice MC, Herda LM, Polo E, Dawson KA. In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry. Nat Commun. 2016;7:1\u201310.","journal-title":"Nat Commun"},{"key":"1748_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010611-134623","volume":"52","author":"SM Moghimi","year":"2012","unstructured":"Moghimi SM, Hunter AC, Andresen TL. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol. 2012;52:481\u2013503.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1748_CR71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/17435889.1.3.297","volume":"1","author":"ML Immordino","year":"2006","unstructured":"Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed. 2006;1:297\u2013315.","journal-title":"Int J Nanomed"},{"key":"1748_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. In Nat Rev Drug Discov. 2005;4:145\u201360.","journal-title":"In Nat Rev Drug Discov"},{"key":"1748_CR73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst JJ, Chen GM, Wang M, Porter DL, Chen C, Collins MA, Gao P, Bandyopadhyay S, Sun H, Zhao Z. Decade-long leukaemia remissions with persistence of CD4 + CAR T cells. Nature. 2022;602:503\u20139.","journal-title":"Nature"},{"key":"1748_CR74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jconrel.2018.08.033","volume":"287","author":"C Sabu","year":"2018","unstructured":"Sabu C, Rejo C, Kotta S, Pramod K. Bioinspired and biomimetic systems for advanced drug and gene delivery. J Control Release. 2018;287:142\u201355.","journal-title":"J Control Release"},{"key":"1748_CR75","first-page":"1","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell Membrane Coating Nanotechnology Adv Mater. 2018;30:1\u201334.","journal-title":"Cell Membrane Coating Nanotechnology Adv Mater"},{"key":"1748_CR76","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2017.08.027","volume":"264","author":"Z Chai","year":"2017","unstructured":"Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, Su B, Ruan H, Ran D, Fang RH, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release. 2017;264:102\u201311.","journal-title":"J Control Release"},{"key":"1748_CR77","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.7150\/thno.14471","volume":"6","author":"BT Luk","year":"2016","unstructured":"Luk BT, Fang RH, Hu CMJ, Copp JA, Thamphiwatana S, Dehaini D, Gao W, Zhang K, Li S, Zhang L. Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics. 2016;6:1004\u201311.","journal-title":"Theranostics"},{"key":"1748_CR78","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/aic.13781","volume":"59","author":"Z Qiao","year":"2012","unstructured":"Qiao Z, Wang Z, Zhang C, Yuan S, Zhu Y, Wang J. Engineering red-blood\u2010cell\u2010membrane\u2013coated nanoparticles for broad biomedical applications. AIChE J. 2012;59:215\u201328.","journal-title":"AIChE J"},{"key":"1748_CR79","doi-asserted-by":"publisher","first-page":"1800053","DOI":"10.1002\/adtp.201800053","volume":"1","author":"T Lang","year":"2018","unstructured":"Lang T, Yin Q, Li Y. Progress of cell-derived Biomimetic Drug Delivery Systems for Cancer Therapy. Adv Ther. 2018;1:1800053\u20133.","journal-title":"Adv Ther"},{"key":"1748_CR80","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1039\/C5NR03730A","volume":"7","author":"Z Wu","year":"2015","unstructured":"Wu Z, Esteban-Fern\u00e1ndez De \u00c1vila B, Mart\u00edn A, Christianson C, Gao W, Thamphiwatana SK, Escarpa A, He Q, Zhang L, Wang J. RBC micromotors carrying multiple cargos towards potential theranostic applications. Nanoscale. 2015;7:13680\u20136.","journal-title":"Nanoscale"},{"key":"1748_CR81","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.addr.2010.06.007","volume":"62","author":"Q Shi","year":"2010","unstructured":"Shi Q, Montgomery RR. Platelets as delivery systems for disease treatments. Adv Drug Deliv Rev. 2010;62:1196\u2013203.","journal-title":"Adv Drug Deliv Rev"},{"key":"1748_CR82","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biomaterials.2016.03.023","volume":"91","author":"O Levy","year":"2016","unstructured":"Levy O, Brennen WN, Han E, Rosen DM, Musabeyezu J, Safaee H, Ranganath S, Ngai J, Heinelt M, Milton Y, et al. A prodrug-doped cellular trojan horse for the potential treatment of prostate cancer. Biomaterials. 2016;91:140\u201350.","journal-title":"Biomaterials"},{"key":"1748_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2015.01.039","volume":"204","author":"J Fu","year":"2015","unstructured":"Fu J, Wang D, Mei D, Zhang H, Wang Z, He B, Dai W, Zhang H, Wang X, Zhang Q. Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Release. 2015;204:11\u20139.","journal-title":"J Control Release"},{"key":"1748_CR84","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.copbio.2013.11.005","volume":"28","author":"JA Rosenthal","year":"2014","unstructured":"Rosenthal JA, Chen L, Baker JL, Putnam D, DeLisa MP. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. Curr Opin Biotechnol. 2014;28:51\u20138.","journal-title":"Curr Opin Biotechnol"},{"key":"1748_CR85","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1182\/blood.V86.1.342.bloodjournal861342","volume":"86","author":"M Paulitschke","year":"1995","unstructured":"Paulitschke M, Nash GB, Anstee DJ, Tanner MJA, Gratzer WB. Perturbation of red blood cell membrane rigidity by extracellular ligands. Blood. 1995;86:342\u20138.","journal-title":"Blood"},{"key":"1748_CR86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrg2985","volume":"12","author":"L Naldini","year":"2011","unstructured":"Naldini L. Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet. 2011;12:301\u201315.","journal-title":"Nat Rev Genet"},{"key":"1748_CR87","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1748_CR88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12195-016-0457-4","volume":"9","author":"TN Lamichhane","year":"2016","unstructured":"Lamichhane TN, Jeyaram A, Patel DB, Parajuli B, Livingston NK, Arumugasaamy N, Schardt JS, Jay SM. Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication. Cell Mol Bioeng. 2016;9:315\u201324.","journal-title":"Cell Mol Bioeng"},{"key":"1748_CR89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","volume":"21","author":"SI Ohno","year":"2013","unstructured":"Ohno SI, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells. Mol Ther. 2013;21:185\u201391.","journal-title":"Mol Ther"},{"key":"1748_CR90","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","volume":"35","author":"Y Tian","year":"2014","unstructured":"Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35:2383\u201390.","journal-title":"Biomaterials"},{"key":"1748_CR91","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1021\/nn100870z","volume":"4","author":"RS Rachakatla","year":"2010","unstructured":"Rachakatla RS, Balivada S, Seo GM, Myers CB, Wang H, Samarakoon TN, Dani R, Pyle M, Kroh FO, Walker B, et al. Attenuation of mouse melanoma by A\/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. ACS Nano. 2010;4:7093\u2013104.","journal-title":"ACS Nano"},{"key":"1748_CR92","first-page":"1525","volume":"7","author":"SAA Kooijmans","year":"2012","unstructured":"Kooijmans SAA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM. Exosome mimetics: a novel class of drug delivery systems. Int J Nanomed. 2012;7:1525\u201341.","journal-title":"Int J Nanomed"},{"key":"1748_CR93","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"CMJ Hu","year":"2011","unstructured":"Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108:10980\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1748_CR94","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1039\/c3nr00015j","volume":"5","author":"CMJ Hu","year":"2013","unstructured":"Hu CMJ, Fang RH, Luk BT, Chen KNH, Carpenter C, Gao W, Zhang K, Zhang L. \u2018marker-of-self\u2019 functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale. 2013;5:2664\u20138.","journal-title":"Nanoscale"},{"key":"1748_CR95","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1039\/C3NR06371B","volume":"6","author":"BT Luk","year":"2014","unstructured":"Luk BT, Jack Hu CM, Fang RH, Dehaini D, Carpenter C, Gao W, Zhang L. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014;6:2730\u20137.","journal-title":"Nanoscale"},{"key":"1748_CR96","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.7150\/thno.20118","volume":"7","author":"Y Zhai","year":"2017","unstructured":"Zhai Y, Su J, Ran W, Zhang P, Yin Q, Zhang Z, Yu H, Li Y. Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy. Theranostics. 2017;7:2575\u201392.","journal-title":"Theranostics"},{"key":"1748_CR97","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1021\/acsnano.8b07241","volume":"13","author":"EM Reuven","year":"2019","unstructured":"Reuven EM, Leviatan Ben-Arye S, Yu H, Duchi R, Perota A, Conchon S, Bachar Abramovitch S, Soulillou JP, Galli C, Chen X, Padler-karavani V. Biomimetic glyconanoparticle vaccine for cancer immunotherapy. ACS Nano. 2019;13:2936\u201347.","journal-title":"ACS Nano"},{"key":"1748_CR98","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jconrel.2019.01.027","volume":"296","author":"X Liang","year":"2019","unstructured":"Liang X, Ye X, Wang C, Xing C, Miao Q, Xie Z, Chen X, Zhang X, Zhang H, Mei L. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release. 2019;296:150\u201361.","journal-title":"J Control Release"},{"key":"1748_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0021-9975(92)90002-C","volume":"107","author":"PA Gentry","year":"1992","unstructured":"Gentry PA. The mammalian blood platelet: its role in haemostasis, inflammation and tissue repair. J Comp Pathol. 1992;107:243\u201370.","journal-title":"J Comp Pathol"},{"key":"1748_CR100","doi-asserted-by":"publisher","first-page":"41697","DOI":"10.1038\/srep41697","volume":"7","author":"A Ojha","year":"2017","unstructured":"Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, Seth T, Dar L, Medigeshi GR, Vrati S, et al. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci Rep. 2017;7:41697.","journal-title":"Sci Rep"},{"key":"1748_CR101","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","volume":"24","author":"D Schumacher","year":"2013","unstructured":"Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 receptor. Cancer Cell. 2013;24:130\u20137.","journal-title":"Cancer Cell"},{"key":"1748_CR102","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123\u201334.","journal-title":"Nat Rev Cancer"},{"key":"1748_CR103","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Sci: Proc Am Assoc Adv Sci. 2011;331:1559\u201364.","journal-title":"Sci: Proc Am Assoc Adv Sci"},{"key":"1748_CR104","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1021\/acsnano.5b01042","volume":"9","author":"Y Guo","year":"2015","unstructured":"Guo Y, Wang D, Song Q, Wu T, Zhuang X, Bao Y, Kong M, Qi Y, Tan S, Zhang Z. Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma. ACS Nano. 2015;9:6918\u201333.","journal-title":"ACS Nano"},{"key":"1748_CR105","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1002\/adfm.201603381","volume":"26","author":"J Su","year":"2016","unstructured":"Su J, Sun H, Meng Q, Yin Q, Zhang P, Zhang Z, Yu H, Li Y. Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer. Adv Funct Mater. 2016;26:7495\u2013506.","journal-title":"Adv Funct Mater"},{"key":"1748_CR106","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7150\/thno.17259","volume":"7","author":"J Su","year":"2017","unstructured":"Su J, Sun H, Meng Q, Zhang P, Yin Q, Li Y. Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with. Erythrocyte Membr Theranostics. 2017;7:523\u201337.","journal-title":"Erythrocyte Membr Theranostics"},{"key":"1748_CR107","doi-asserted-by":"publisher","first-page":"10414","DOI":"10.1021\/nn503779d","volume":"8","author":"J-G Piao","year":"2014","unstructured":"Piao J-G, Wang L, Gao F, You Y-Z, Xiong Y, Yang L. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano. 2014;8:10414\u201325.","journal-title":"ACS Nano"},{"key":"1748_CR108","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1002\/adma.201503323","volume":"27","author":"Q Hu","year":"2015","unstructured":"Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z. Anticancer platelet-mimicking nanovehicles. Adv Mater. 2015;27:7043\u201350.","journal-title":"Adv Mater"},{"key":"1748_CR109","doi-asserted-by":"publisher","first-page":"1605803","DOI":"10.1002\/adma.201605803","volume":"29","author":"Q Hu","year":"2017","unstructured":"Hu Q, Sun W, Qian C, Bomba HN, Xin H, Gu Z. Relay drug delivery for amplifying targeting signal and enhancing anticancer efficacy. Adv Mater. 2017;29:1605803\u20133.","journal-title":"Adv Mater"},{"key":"1748_CR110","doi-asserted-by":"publisher","first-page":"28254","DOI":"10.1021\/acsami.9b04735","volume":"11","author":"Y Shang","year":"2019","unstructured":"Shang Y, Wang Q, Wu B, Zhao Q, Li J, Huang X, Chen W, Gui R. Platelet-membrane-camouflaged black phosphorus quantum dots enhance anticancer effect mediated by apoptosis and autophagy. ACS Appli Mater Interfaces. 2019;11:28254\u201366.","journal-title":"ACS Appli Mater Interfaces"},{"key":"1748_CR111","doi-asserted-by":"publisher","first-page":"1604774","DOI":"10.1002\/adfm.201604774","volume":"27","author":"L Rao","year":"2017","unstructured":"Rao L, Bu L-L, Meng Q-F, Cai B, Deng W-W, Li A, Li K, Guo S-S, Zhang W-F, Liu W, et al. Antitumor platelet-mimicking magnetic nanoparticles. Adv Funct Mater. 2017;27:1604774.","journal-title":"Adv Funct Mater"},{"key":"1748_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.024","volume":"206","author":"H Ye","year":"2019","unstructured":"Ye H, Wang K, Wang M, Liu R, Song H, Li N, Lu Q, Zhang W, Du Y, Yang W, et al. Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials. 2019;206:1\u201312.","journal-title":"Biomaterials"},{"key":"1748_CR113","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nnano.2017.54","volume":"12","author":"J Xue","year":"2017","unstructured":"Xue J, Zhao Z, Zhang L, Xue L, Shen S, Wen Y, Wei Z, Wang L, Kong L, Sun H, et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol. 2017;12:692\u2013700.","journal-title":"Nat Nanotechnol"},{"key":"1748_CR114","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.apsb.2018.12.009","volume":"9","author":"X Cao","year":"2019","unstructured":"Cao X, Hu Y, Luo S, Wang Y, Gong T, Sun X, Fu Y, Zhang Z. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm Sinic B. 2019;9:575\u201389.","journal-title":"Acta Pharm Sinic B"},{"key":"1748_CR115","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nnano.2012.212","volume":"8","author":"A Parodi","year":"2013","unstructured":"Parodi A, Quattrocchi N, Van De Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013;8:61\u20138.","journal-title":"Nat Nanotechnol"},{"key":"1748_CR116","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-14-3095","volume":"75","author":"Q Wang","year":"2015","unstructured":"Wang Q, Ren Y, Mu J, Egilmez NK, Zhuang X, Deng Z, Zhang L, Yan J, Miller D, Zhang H-G. Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Res. 2015;75:2520\u20139.","journal-title":"Cancer Res"},{"issue":"13","key":"1748_CR117","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2174\/1389450115666141109211413","volume":"16","author":"C Corbo","year":"2015","unstructured":"Corbo C, Parodi A, Evangelopoulos M, Engler A, Matsunami DK, Engler RC, Molinaro A, Scaria R, Salvatore S, Tasciotti F. Proteomic profiling of a biomimetic drug delivery platform. Curr drug targets. 2015;16(13):1540\u20137.","journal-title":"Curr drug targets"},{"key":"1748_CR118","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1021\/acsami.6b00853","volume":"8","author":"M Xuan","year":"2016","unstructured":"Xuan M, Shao J, Dai L, Li J, He Q. Macrophage cell membrane camouflaged au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces. 2016;8:9610\u20138.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1748_CR119","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jbm.a.35927","volume":"105","author":"L Rao","year":"2017","unstructured":"Rao L, He Z, Meng Q-F, Zhou Z, Bu L-L, Guo S-S, Liu W, Zhao X-Z. Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles. J Biomed Mater Res A. 2017;105:521\u201330.","journal-title":"J Biomed Mater Res A"},{"key":"1748_CR120","doi-asserted-by":"publisher","first-page":"23441","DOI":"10.1021\/acsami.7b05766","volume":"9","author":"S N\u00e4kki","year":"2017","unstructured":"N\u00e4kki S, Martinez JO, Evangelopoulos M, Xu W, Lehto VP, Tasciotti E. Chlorin e6 functionalized theranostic multistage nanovectors transported by stem cells for effective photodynamic therapy. ACS Appl Mater Interfaces. 2017;9:23441\u20139.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"30","key":"1748_CR121","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1002\/smll.201600624","volume":"12","author":"G Changyong","year":"2016","unstructured":"Changyong G, Jurado-S\u00e1nchez B. Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small. 2016;12(30):4056\u201362.","journal-title":"Small"},{"key":"1748_CR122","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1038\/ncomms13724","volume":"8","author":"J Tang","year":"2017","unstructured":"Tang J, Shen D, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, Hensley MT, Dinh P-U, Cores J, Li T-S, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8:13724.","journal-title":"Nat Commun"},{"key":"1748_CR123","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","volume":"16","author":"J-Y Zhu","year":"2016","unstructured":"Zhu J-Y, Zheng D-W, Zhang M-K, Yu W-Y, Qiu W-X, Hu J-J, Feng J, Zhang X-Z. Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett. 2016;16:5895\u2013901.","journal-title":"Nano Lett"},{"key":"1748_CR124","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","volume":"14","author":"RH Fang","year":"2014","unstructured":"Fang RH, Hu CMJ, Luk BT, Gao W, Copp JA, Tai Y, O\u2019Connor DE, Zhang L. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14:2181\u20138.","journal-title":"Nano Lett"},{"key":"1748_CR125","doi-asserted-by":"publisher","first-page":"9581","DOI":"10.1002\/adma.201602173","volume":"28","author":"H Sun","year":"2016","unstructured":"Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W, Zhang P, Zhang Z, Yu H, Wang S, Li Y. Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors. Adv Mater. 2016;28:9581\u20138.","journal-title":"Adv Mater"},{"key":"1748_CR126","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1002\/adma.201506086","volume":"28","author":"L Rao","year":"2016","unstructured":"Rao L, Bu L-L, Cai B, Xu J-H, Li A, Zhang W-F, Sun Z-J, Guo S-S, Liu W, Wang T-H, Zhao X-Z. Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging. Adv Mater. 2016;28:3460\u20136.","journal-title":"Adv Mater"},{"key":"1748_CR127","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.colsurfb.2018.12.038","volume":"175","author":"C-M Liu","year":"2019","unstructured":"Liu C-M, Chen G-B, Chen H-H, Zhang J-B, Li H-Z, Sheng M-X, Weng W-B, Guo S-M. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Colloids Surf B. 2019;175:477\u201386.","journal-title":"Colloids Surf B"},{"key":"1748_CR128","first-page":"27","volume":"3","author":"H Sun","year":"2017","unstructured":"Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W, Zhang Z, Yu H, Zhang P, Wang S, Li Y. Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer. Adv Funct Mater. 2017;3:27.","journal-title":"Adv Funct Mater"},{"key":"1748_CR129","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1021\/nl504798g","volume":"15","author":"W Gao","year":"2015","unstructured":"Gao W, Fang RH, Thamphiwatana S, Luk BT, Li J, Angsantikul P, Zhang Q, Hu C-MJ, Zhang L. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett. 2015;15:1403\u20139.","journal-title":"Nano Lett"},{"key":"1748_CR130","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1002\/anie.201906280","volume":"58","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen Y, Lo C, Zhuang J, Angsantikul P, Zhang Q, Wei X, Zhou Z, Obonyo M, Fang RH. Inhibition of pathogen adhesion by bacterial outer membrane-coated nanoparticles. Angew Chem Int Ed. 2019;58:11404\u20138.","journal-title":"Angew Chem Int Ed"},{"key":"1748_CR131","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.nano.2019.102084","volume":"23","author":"M Hafsi","year":"2020","unstructured":"Hafsi M, Preveral S, Hoog C, H\u00e9rault J, Perrier GA, Lef\u00e8vre CT, Michel H, Pignol D, Doyen J, Pourcher T. RGD-functionalized magnetosomes are efficient tumor radioenhancers for X-rays and protons. Nanotechnol Biol Med. 2020;23:102084.","journal-title":"Nanotechnol Biol Med"},{"key":"1748_CR132","doi-asserted-by":"publisher","first-page":"1902626","DOI":"10.1002\/adma.201902626","volume":"31","author":"RB Patel","year":"2019","unstructured":"Patel RB, Ye M, Carlson PM, Jaquish A, Zangl L, Ma B, Wang Y, Arthur I, Xie R, Brown RJ. Development of an in situ cancer vaccine via combinational radiation and bacterial-membrane\u2010coated nanoparticles. Adv Mater. 2019;31:1902626.","journal-title":"Adv Mater"},{"key":"1748_CR133","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nmat4644","volume":"15","author":"R Molinaro","year":"2016","unstructured":"Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S, Yazdi IK, Zhao P, De Rosa E, Sherman MB, et al. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater. 2016;15:1037\u201346.","journal-title":"Nat Mater"},{"key":"1748_CR134","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.7150\/thno.22078","volume":"8","author":"JO Martinez","year":"2018","unstructured":"Martinez JO, Molinaro R, Hartman KA, Boada C, Sukhovershin R, De Rosa E, Kirui D, Zhang S, Evangelopoulos M, Carter AM, et al. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery. Theranostics. 2018;8:1131\u201345.","journal-title":"Theranostics"},{"key":"1748_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08687-3","volume":"7","author":"B Corradetti","year":"2017","unstructured":"Corradetti B, Taraballi F, Martinez JO, Minardi S, Basu N, Bauza G, Evangelopoulos M, Powell S, Corbo C, Tasciotti E. Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation. Sci Rep. 2017;7:1\u201312.","journal-title":"Sci Rep"},{"key":"1748_CR136","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1021\/nl401376w","volume":"13","author":"NE Toledano Furman","year":"2013","unstructured":"Toledano Furman NE, Lupu-Haber Y, Bronshtein T, Kaneti L, Letko N, Weinstein E, Baruch L, Machluf M. Reconstructed stem cell nanoghosts: a natural tumor targeting platform. Nano Lett. 2013;13:3248\u201355.","journal-title":"Nano Lett"},{"key":"1748_CR137","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177\u201393.","journal-title":"CA Cancer J Clin"},{"key":"1748_CR138","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1593\/neo.06493","volume":"8","author":"J Heimburg","year":"2006","unstructured":"Heimburg J, Yan J, Morey S, Glinskii OV, Huxley VH, Wild L, Klick R, Roy R, Glinsky VV, Rittenhouse-Olson K. Inhibition of spontaneous breast cancer metastasis by anti\u2014Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia. 2006;8:939\u201348.","journal-title":"Neoplasia"},{"key":"1748_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-154","volume":"9","author":"Q Zhao","year":"2010","unstructured":"Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM, Yu LG. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer. 2010;9:1\u201312.","journal-title":"Mol Cancer"},{"key":"1748_CR140","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3:453\u20138.","journal-title":"Nat Rev Cancer"},{"key":"1748_CR141","first-page":"3805","volume":"63","author":"VV Glinsky","year":"2003","unstructured":"Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ, Quinn TP. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 2003;63:3805\u201311.","journal-title":"Cancer Res"},{"key":"1748_CR142","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0065-230X(08)60101-3","volume":"71","author":"D Naor","year":"1997","unstructured":"Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241\u2013319.","journal-title":"Adv Cancer Res"},{"key":"1748_CR143","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10585-012-9471-7","volume":"29","author":"K Ito","year":"2012","unstructured":"Ito K, Ralph SJ. Inhibiting galectin-1 reduces murine lung metastasis with increased CD4 + and CD8 + T cells and reduced cancer cell adherence. Clin Exp Metastasis. 2012;29:561\u201372.","journal-title":"Clin Exp Metastasis"},{"key":"1748_CR144","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1021\/acsnano.7b08355","volume":"12","author":"D Wang","year":"2018","unstructured":"Wang D, Dong H, Li M, Cao Y, Yang F, Zhang K, Dai W, Wang C, Zhang X. Erythrocyte\u2013cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal\/chemotherapy of melanoma. ACS Nano. 2018;12:5241\u201352.","journal-title":"ACS Nano"},{"key":"1748_CR145","doi-asserted-by":"publisher","first-page":"1703969","DOI":"10.1002\/adma.201703969","volume":"29","author":"AV Kroll","year":"2017","unstructured":"Kroll AV, Fang RH, Jiang Y, Zhou J, Wei X, Yu CL, Gao J, Luk BT, Dehaini D, Gao W, Zhang L. Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity. Adv Mater. 2017;29:1703969\u20139.","journal-title":"Adv Mater"},{"key":"1748_CR146","doi-asserted-by":"publisher","first-page":"1603239","DOI":"10.1002\/adma.201603239","volume":"29","author":"F Fontana","year":"2017","unstructured":"Fontana F, Shahbazi MA, Liu D, Zhang H, M\u00e4kil\u00e4 E, Salonen J, Hirvonen JT, Santos HA. Multistaged nanovaccines based on porous silicon@acetalated dextran@cancer cell membrane for cancer immunotherapy. Adv Mater. 2017;29:1603239\u20139.","journal-title":"Adv Mater"},{"key":"1748_CR147","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrc1815","volume":"6","author":"P-L Lollini","year":"2006","unstructured":"Lollini P-L, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nat Rev Cancer. 2006;6:204\u201316.","journal-title":"Nat Rev Cancer"},{"key":"1748_CR148","doi-asserted-by":"publisher","first-page":"230","DOI":"10.7150\/jca.1.230","volume":"1","author":"PG Lokhov","year":"2010","unstructured":"Lokhov PG, Balashova EE. Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens. J Cancer. 2010;1:230\u201341.","journal-title":"J Cancer"},{"key":"1748_CR149","doi-asserted-by":"publisher","first-page":"2102580","DOI":"10.1002\/adma.202102580","volume":"33","author":"Z Li","year":"2021","unstructured":"Li Z, Wang Y, Liu J, Rawding P, Bu J, Hong S, Hu Q. Chemically and biologically engineered bacteria-based delivery systems for emerging diagnosis and advanced therapy. Adv Mater. 2021;33:2102580.","journal-title":"Adv Mater"},{"key":"1748_CR150","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/pmic.200700196","volume":"7","author":"EY Lee","year":"2007","unstructured":"Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, Park KS, Lee JO, Kim YK, Kwon KH. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics. 2007;7:3143\u201353.","journal-title":"Proteomics"},{"key":"1748_CR151","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1101\/gad.1299905","volume":"19","author":"MJ Kuehn","year":"2005","unstructured":"Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host\u2013pathogen interaction. Genes Dev. 2005;19:2645\u201355.","journal-title":"Genes Dev"},{"key":"1748_CR152","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1002\/pmic.200800273","volume":"8","author":"A Poetsch","year":"2008","unstructured":"Poetsch A, Wolters D. Bacterial membrane proteomics. Proteomics. 2008;8:4100\u201322.","journal-title":"Proteomics"},{"key":"1748_CR153","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","volume":"5","author":"R Acevedo","year":"2014","unstructured":"Acevedo R, Fern\u00e1ndez S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, Rosenqvist E, Campa C, Cardoso D, Garcia L. Bacterial outer membrane vesicles and vaccine applications. Front Immunol. 2014;5:121.","journal-title":"Front Immunol"},{"key":"1748_CR154","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcdb.2016.12.001","volume":"67","author":"OY Kim","year":"2017","unstructured":"Kim OY, Lee J, Gho YS. Extracellular vesicle mimetics: novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines. Semin Cell Dev Biol. 2017;67:74\u201382.","journal-title":"Semin Cell Dev Biol"},{"key":"1748_CR155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim OY, Park HT, Dinh NTH, Choi SJ, Lee J, Kim JH, Lee S-W, Gho YS. Bacterial outer membrane vesicles suppress tumor by interferon-\u03b3-mediated antitumor response. Nat Commun. 2017;8:1\u20139.","journal-title":"Nat Commun"},{"key":"1748_CR156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"K Cheng","year":"2021","unstructured":"Cheng K, Zhao R, Li Y, Qi Y, Wang Y, Zhang Y, Qin H, Qin Y, Chen L, Li C. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology. Nat Commun. 2021;12:1\u201316.","journal-title":"Nat Commun"},{"key":"1748_CR157","doi-asserted-by":"publisher","first-page":"2100088","DOI":"10.1002\/adfm.202100088","volume":"31","author":"Z Li","year":"2021","unstructured":"Li Z, Wang Y, Ding Y, Repp L, Kwon GS, Hu Q. Cell-based delivery systems: emerging carriers for immunotherapy. Adv Funct Mater. 2021;31::2100088.","journal-title":"Adv Funct Mater"},{"key":"1748_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-015-0351-6","volume":"15","author":"JP Brooks","year":"2015","unstructured":"Brooks JP, Edwards DJ, Harwich MD, Rivera MC, Fettweis JM, Serrano MG, Reris RA, Sheth NU, Huang B, Girerd P. The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 2015;15:1\u201314.","journal-title":"BMC Microbiol"},{"key":"1748_CR159","doi-asserted-by":"publisher","first-page":"114294","DOI":"10.1016\/j.addr.2022.114294","volume":"185","author":"N Krishnan","year":"2022","unstructured":"Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev. 2022;185:114294.","journal-title":"Adv Drug Deliv Rev"},{"key":"1748_CR160","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.biochem.0c00343","volume":"60","author":"X Ai","year":"2020","unstructured":"Ai X, Wang S, Duan Y, Zhang Q, Chen MS, Gao W, Zhang L. Emerging approaches to functionalizing cell membrane-coated nanoparticles. Biochemistry. 2020;60:941\u201355.","journal-title":"Biochemistry"},{"key":"1748_CR161","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/adfm.201504780","volume":"26","author":"J Su","year":"2016","unstructured":"Su J, Sun H, Meng Q, Yin Q, Tang S, Zhang P, Chen Y, Zhang Z, Yu H, Li Y. Long circulation red-blood\u2010cell\u2010mimetic nanoparticles with peptide\u2010enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer. Adv Funct Mater. 2016;26:1243\u201352.","journal-title":"Adv Funct Mater"},{"key":"1748_CR162","doi-asserted-by":"publisher","first-page":"119576","DOI":"10.1016\/j.biomaterials.2019.119576","volume":"229","author":"J Wang","year":"2020","unstructured":"Wang J, Wang Z, Zhong Y, Zou Y, Wang C, Wu H, Lee A, Yang W, Wang X, Liu Y. Central metal-derived co-assembly of biomimetic GdTPP\/ZnTPP porphyrin nanocomposites for enhanced dual-modal imaging-guided photodynamic therapy. Biomaterials. 2020;229:119576.","journal-title":"Biomaterials"},{"key":"1748_CR163","doi-asserted-by":"publisher","first-page":"1903301","DOI":"10.1002\/advs.201903301","volume":"7","author":"S Cheng","year":"2020","unstructured":"Cheng S, Xu C, Jin Y, Li Y, Zhong C, Ma J, Yang J, Zhang N, Li Y, Wang C. Artificial mini dendritic cells boost T cell\u2013based immunotherapy for ovarian cancer. Adv Sci. 2020;7:1903301.","journal-title":"Adv Sci"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01748-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T06:28:43Z","timestamp":1701584923000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01748-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}